Table 2.
Association between the pre, intra and postoperative and survival at different points in time with survival and CI 95% (lower lim - upper lim). São Paulo, Brazil 2014.
| Time since surgery | 30 days | 180 days | 1 year | 2 years | 3 and 4 years | P-valuea | |
|---|---|---|---|---|---|---|---|
| Overall survival | 62.8% (55.3-70.4) |
36.2% (28.7-43.8) |
32.1% (24.7-39.5) |
29.9% (22.6-37.2) |
27.6% (20.2-35.0) |
||
| Preoperative | |||||||
| Age | <60 years old | 78.6% (69.0-88.2) |
46.5% (34.7-58.3) |
43.2% (31.4-55.0) |
41.5% (29.8-53.3) |
38.8% (26.6-51.0) |
0.001 |
| >60 years old | 50.0% (39.4-60.6) |
27.9% (18.4-37.4) |
23.3% (14.3-32.2) |
20.9% (12.3-29.5) |
19.0% (10.4-27.6) |
||
| Sex | Female | 67.7% (56.3-79.1) |
30.7% (19.5-41.9) |
29% (17.9-40.1) |
27.3% (16.3-38.2) |
27.3% (16.3-38.2) |
0.933 |
| Male | 59.4% (49.3-69.5) |
40.3% (30.2-50.5) |
34.4% (24.5-44.3) |
31.7% (21.9-41.5) |
27.6% (17.5-37.7) |
||
| Comorbidities | Diabetes mellitus | 72.8% (61.8-83.9) |
38.8% (26.6-50.9) |
28.2% (16.8-39.6) |
28.2% (16.8-39.6) |
25.1% (13.4-36.7) |
0.642 |
| Hypertension | 64.4% (56.3-72.6) |
39.1% (30.7-47.4) |
34.1% (25.9-42.3) |
31.5% (23.4-39.6) |
28.5% (20.2-36.8) |
0.26 | |
| Dyslipidemia | 65.7% (56.2-75.2) |
40.1% (30.3-50.0) |
34.4% (24.7-44.1) |
31.9% (22.3-41.5) |
27.8% (17.8-37.7) |
0.373 | |
| Prior AMI | 73.4% (55.2-91.7) |
45.4% (24.4-66.4) |
40.4% (19.5-61.3) |
35.3% (14.9-55.8) |
23.6% (0.3-46.8) |
0.477 | |
| BMI | <25 | 65.5% (52.9-78.0) |
40.0% (27.1-52.9) |
35.8% (23.0-48.6) |
33.4% (20.6-46.2) |
30.6% (17.8-43.5) |
0.834 |
| 25-29.9 | 64.7% (51.1-78.2) |
34.4% (20.7-48.0) |
32.1% (18.6-45.5) |
29.8% (16.6-43.0) |
29.8% (16.6-43.0) |
||
| ≥30 | 62.2% (48.1-76.4) |
35.6% (21.6-49.5) |
28.9% (15.6-42.1) |
26.7% (13.7-39.6) |
21.3% (7.4-35.3) |
||
| GFR | GFR I – Normal | 63.7% (40.4-87.0) |
25.5% (4.0-47.0) |
19.1% (0.0-38.5) |
19.1% (0.0-38.5) |
19.1% (0.0-38.5) |
0.017 |
| GFR II - Mild | 53.3% (38.8-67.9) |
31.1% (17.6-44.6) |
28.7% (15.4-42.0) |
26.3% (13.4-39.3) |
26.3% (13.4-39.3) |
||
| GFR III - Moderate | 60.0% (46.4-73.6) |
34.0% (20.9-47.1) |
28.0% (15.6-40.4) |
25.8% (13.7-38.0) |
23.0% (10.9-35.0) |
||
| GFR IV – Severeb | 50.0% (15.4-84.6) |
12.5% (0.0-35.4) |
12.5% (0.0-35.4) |
12.5% (0.0-35.4) |
12.5% (0.0-35.4) |
||
| GFR V - Kidney failureb | 81.8% (68.7-95.0) |
59.8% (42.8-76.7) |
56.1% (38.7-73.4) |
52.3% (34.6-70.0) |
46.5% (27.4-65.6) |
||
| Intraoperative | |||||||
| Type of surgery | Myocardial revascularization | 71.4% (59.6-83.3) |
44.6% (31.5-57.6) |
35.3% (22.7-47.9) |
33.4% (21.0-45.9) |
27.0% (14.1-39.9) |
0.171 |
| Valve | 57.2% (46.2-68.3) |
34.6% (23.8-45.3) |
33.1% (22.4-43.7) |
31.6% (21.0-42.1) |
31.6% (21.0-42.1) |
||
| Correction aorta aneurysm | 100.0% (29.0-100) |
66.7% (13.3-100.0) |
66.7% (13.3-100.0) |
33.3% (0-86.7) |
33.3% (0-86.7) |
||
| Combined | 55.0% (33.2-76.8) |
15.0% (0.0-30.6) |
15.0% (0.0-30.6) |
15.0% (0.0-30.6) |
15.0% (0.0-30.6) |
||
| CPB time | < 120min | 63.4% (53.0-73.8) |
46.3% (35.3-57.1) |
41.1% (30.4-51.8) |
37.0% (26.3-47.6) |
34.9% (24.1-45.7) |
0.054 |
| ≥ 120min | 62.1% (51.0-73.2) |
24.7% (14.8-34.7) |
21.8% (12.2-31.4) |
21.8% (12.2-31.4) |
19.4% (9.8-29.0) |
||
| Vasoactive drugs | 62.7% (54.5-70.9) |
34.7% (26.6-42.8) |
31.4% (23.5-39.4) |
29.8% (21.9-37.6) |
26.8% (18.8-34.9) |
0.519 | |
| Postoperative | |||||||
| Vasoactive drugs | 63.4% (55.6-71.1) |
35.7% (28.0-43.4) |
31.3% (23.8-38.8) |
29.0% (21.6-36.4) |
26.6% (19.2-34.1) |
0.25 | |
| Blood transfusion | 57.6% (47.0-68.3) |
30.6% (20.7-40.6) |
29.4% (19.5-39.3) |
25.6% (16.0-35.1) |
23.8% (14.4-33.3) |
0.16 | |
| Low cardiac output | 61.1% (38.6-83.6) |
24.4% (3.8-45.1) |
24.4% (3.8-45.1) |
24.4% (3.8-45.1) |
24.4% (3.8-45.1) |
0.53 | |
| No. of complications | 0 | 88.5% (73.6-100.0) |
82.6% (64.8-100.0) |
62.4% (38.3-86.5) |
62.4% (38.3-86.5) |
41.6% (4.6-78.6) |
0.0003 |
| 1 | 71.4% (56.5-86.4) |
51.4% (34.9-68.0) |
48.2% (31.5-64.9) |
41.8% (25.1-58.5) |
41.8% (25.1-58.5) |
||
| 2 or more | 55.6% (46.0-65.2) |
23.4% (15.2-31.6) |
21.5% (13.5-29.4) |
20.5% (12.7-28.3) |
15.3% (6.2-24.4) |
||
| Length of stay in ICU (Days) | 1-3 | 66.7% (51.3-82.1) |
44.4% (28.2-60.7) |
41.0% (24.7-57.3) |
34.2% (18.1-50.3) |
29.3% (12.9-45.7) |
|
| 4-10 | 63.2% (47.8-78.5) |
44.7% (28.9-60.5) |
36.8% (21.5-52.2) |
36.8% (21.5-52.2) |
36.8% (21.5-52.2) |
||
| 11-30 | 34.0% (20.5-47.4) |
21.2% (9.6-32.9) |
21.2% (9.6-32.9) |
21.2% (9.6-32.9) |
21.2% (9.6-32.9) |
0.088 | |
| >30 | 100.0% (88.4-100.0) |
33.0% (16.0-50.0) |
29.3% (12.8-45.9) |
25.1% (9.1-41.2) |
20.1% (4.5-35.7) |
||
AMI=acute myocardial infarction; BMI=body mass index; GFR=glomerular filtration rate
a
Long-rank test;
b
P<0.05 pairwise with Bonferroni correct. Value are n (%)